United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

thornton & ross ltd - olive oil - not applicable

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

live, oral) drops (glaxosmithkline uk ltd - human poliovirus live attenuated - oral drops

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - olive oil - not applicable

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

live) vv lister/cep suspension 0.25ml vials (secretary of state for health - vaccinia virus live (lister strain) - liquid

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - olive oil (unii: 6uyk2w1w1e) (olive oil - unii:6uyk2w1w1e), soybean oil (unii: 241atl177a) (soybean oil - unii:241atl177a) - olive oil 16 g in 100 ml - clinolipid is indicated in adults for providing a source of calories and essential fatty acids for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. limitations of use   clinolipid is not indicated for use in pediatric patients because there is insufficient data to demonstrate that clinolipid provides sufficient amounts of essential fatty acids in this population. [see use in specific populations (8.4) ] the omega-3: omega-6 fatty acid ratio in clinolipid has not been shown to improve clinical outcomes compared to other intravenous lipid emulsions. [see clinical studies (14) ] the use of clinolipid is contraindicated in patients with the following: the limited available data on the use of clinolipid in pregnant women are not sufficient to inform a drug-associated risk. however, there are clinical considerations if clinolipid is used in pregnant women [see clinical considerations]. animal reproduction studies have not been conducted with lipid injectab

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - live marek's disease virus serotype 3 - unknown - live marek's disease virus serotype 3 vaccine-general active 0.0 - active constituent

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil, quantity: 0 qs; soya oil, quantity: 0 qs - injection, emulsion - excipient ingredients: sodium oleate; egg lecithin; sodium hydroxide; glycerol; ascorbyl palmitate; water for injections - parenteral nutrition when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - live varicella vaccine, quantity: 2700 pfu/ml - injection, powder for - excipient ingredients: monosodium glutamate monohydrate; urea; sodium chloride; potassium chloride; sucrose; hydrolysed gelatin; monobasic potassium phosphate; dibasic sodium phosphate - varivax refrigerated is indicated for vaccination against varicella in healthy individuals 12 months of age and older.,see the australian immunisation handbook for vaccination recommendations and schedule.,groups who would particularly benefit from vaccination include:,? non-immune adults, especially those in at-risk occupations such as health-care workers, teachers and workers in children?s day-care centres.,? non-immune parents of young children.,? non-immune household contacts, both adults and children, of immunocompromised patients with no history of disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - levonorgestrel, quantity: 52 mg - drug delivery system, intrauterine - excipient ingredients: dimethylsiloxane/methylvinylsiloxane cross linked elastomer - contraception. treatment of idiopathic menorrhagia. prevention of endometrial hyperplasia during oestrogen replacement therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine -